Why I believe nanoparticles are crucial as a carrier for targeted drug delivery

Nanoparticles are the only materials small enough to target cells in the body, and therefore are crucial to targeted drug delivery. Issues with the synthesis, consistency, and bioactivity of these molecules are still being addressed, but base on current proof of concept studies there is a reason to...

Full description

Saved in:
Bibliographic Details
Published in:Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 2013-09, Vol.5 (5), p.423-429
Main Author: Baker Jr, James R.
Format: Article
Language:English
Subjects:
Animals
Arthritis - drug therapy
Biochemistry
Biological activity
Carriers
Cell Line, Tumor
Chemical synthesis
Clinical Trials as Topic
Conflicts of interest
Consistency
Dendrimers - chemistry
Diagnostic software
Diagnostic systems
Drug Carriers
Drug delivery
Drug Delivery Systems
Drug discovery
Humans
Nanomedicine - methods
Nanoparticles
Nanoparticles - chemistry
Nanostructure
Nanotechnology
Neoplasms - drug therapy
Pharmaceutical Preparations - administration & dosage
Synthesis
Websites
Wire
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nanoparticles are the only materials small enough to target cells in the body, and therefore are crucial to targeted drug delivery. Issues with the synthesis, consistency, and bioactivity of these molecules are still being addressed, but base on current proof of concept studies there is a reason to believe that the ‘holy grail’ of targeted drug delivery might someday be achieved using nanoparticle‐based systems. WIREs Nanomed Nanobiotechnol 2013. doi: 10.1002/wnan.1226 This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Diagnostic Tools > In Vitro Nanoparticle-Based Sensing Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease
ISSN:1939-5116
1939-0041
DOI:10.1002/wnan.1226